Clinical outcomes of long-term infliximab treatment for 15 years in patients with Crohn’s disease: a retrospective study

Early clinical remission was not associated with the adherence to IFX treatment. Previous surgery may be an independent risk factor for long-term IFX treatment failure.

Authors

Institutions

Publication Details

Journal
Expert Opinion on Biological Therapy
Published
2026-02-01
DOI
https://doi.org/10.1080/14712598.2026.2635521
Primary Topic
Inflammatory Bowel Disease
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Clinical outcomes of long-term infliximab treatment for 15 years in patients with Crohn’s disease: a retrospective study

Xiaojun Zhuang, Tong Li, Zhirong Zeng, Jieqing Huang et al.
Expert Opinion on Biological Therapy
Inflammatory Bowel Disease
article

Clinical outcomes of long-term infliximab treatment for 15 years in patients with Crohn’s disease: a retrospective study

Xiaojun Zhuang, Tong Li, Zhirong Zeng, Jieqing Huang, LinXin Liu, Mengqi Chen, Zihan Chen
article en

Abstract

Early clinical remission was not associated with the adherence to IFX treatment. Previous surgery may be an independent risk factor for long-term IFX treatment failure.

Expert Opinion on Biological TherapyVol. 26(2)
Dalian Medical University (CN), Institute of Marine Biotechnology (DE), First Affiliated Hospital of Dalian Medical University (CN)
Good health and well-being
Openalex Percentile: Top 46%
Inflammatory Bowel Disease
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.